Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Marshall S. Stanton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James P. Mackin - $9.72M of AORT open-market activity in the last 12 months
- Jean F. Holloway - $2.21M of AORT open-market activity in the last 12 months
- John E. Davis - $1.52M of AORT open-market activity in the last 12 months
- Andrew M. Green - $928K of AORT open-market activity in the last 12 months
- Lance A. Berry - $803K of AORT open-market activity in the last 12 months
- Amy Horton - $667K of AORT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Marshall S. Stanton?
Marshall S. Stanton is a corporate insider, tracked as SVP, Clinical & MD Affair of ARTIVION, INC. (AORT). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Marshall S. Stanton last file a Form 4?
The most recent primary Form 4 on record is dated 4 March 2026, one of 7 filings going back to 2025.
Has Marshall S. Stanton been buying or selling stock?
Recorded transactions: 0 open-market purchases and 10 open-market sales ($2.09M) across all tracked filings.
Where can I see all of Marshall S. Stanton's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Marshall S. Stanton and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
